Apolipoprotein F deficiency is defined as absence of the protein from plasma. No lipid abnormalities are observed. Whether the progression of atherosclerosis is changed has yet to be determined.
|
|
|
|||
|
|
|
|||
|
|
|
|||
|
|
|
|||
|
|
|
|||
|
|
|
|||
|
|
|
|||
|
|
|
|||
|
|
|
|||
|
|
|
|||
|
|
|
|||
|
|
|
|
||
|
|
|
|||
|
|
|
|||
| 1. |
Lagor WR et al. (2009) Overexpression of apolipoprotein F reduces HDL cholesterol levels in vivo.
|
| 2. |
Olofsson SO et al. (1978) Isolation and partial characterization of a new acidic apolipoprotein (apolipoprotein F) from high density lipoproteins of human plasma.
|
| 3. |
Lagor WR et al. (2012) The effects of apolipoprotein F deficiency on high density lipoprotein cholesterol metabolism in mice.
|
| 4. |
Koren E et al. (1982) Isolation and characterization of simple and complex lipoproteins containing apolipoprotein F from human plasma.
|
| 5. |
Day JR et al. (1994) Purification and molecular cloning of human apolipoprotein F.
|
| 6. |
Wang X et al. (1999) Molecular cloning and expression of lipid transfer inhibitor protein reveals its identity with apolipoprotein F.
|
| 7. |
OMIM.ORG article Omim 107760
|